Katholisches Klinikum Mainz, Sankt Hildegardis-Krankenhaus

Mainz, Rhineland-Palatinate 55131

0 studies enrolling now · 1 studies all time

What they study most

Non-Small Cell Lung Cancer

Studies at this site

• TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy — Stopped early